Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple chair test may predict heart failure prognosis

NCT ID NCT07045649

Knowledge-focused Sponsor: Centro Universitário Augusto Motta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study looks at whether a quick, simple test—standing up and sitting down from a chair as many times as possible in one minute—can help predict how heart failure patients will fare after leaving the hospital. Researchers will follow 68 adults hospitalized for decompensated heart failure, checking if their test performance at discharge is linked to death or readmission within 90 days. If the test proves useful, it could offer an easy, low-cost way to identify patients who need extra support after they go home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple, low-cost tool to identify heart failure patients at higher risk of readmission or death after hospital discharge.
What could go wrong
This is a small, observational study, so results may not apply to all heart failure patients. The test may not reliably predict outcomes in larger or more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients diagnosed with CDI

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with CDI; * Over 18 years of age; * With an Intensive Care Unit Mobility Scale (IMS) \> 4 at discharge from the ICU; * Able to sit and stand up from a chair without support from the upper limbs (ULs) will be included in the study. Exclusion Criteria: * Patients with cognitive alterations; * Level of consciousness, with \[RASS (Richmond Agitation and Sedation Scale) \>+1 or \<-2 and Glasgow \<13 (Coma Scale)\], neurological and orthopedic, which compromise the understanding and performance of the assessment will be excluded; * Patients with advanced invasive ventilatory and circulatory support or in cardiogenic shock.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure heart failure mild heart failure moderate heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure Heart failure nyha class II Heart failure nyha class III Heart failure nyha class IV Heart failure; with decompensation

Contacts and locations

Locations

  • Hospital Universitário Pedro Ernesto

    Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.